LabCorp to purchase Genzyme's genetic testing business

CAMBRIDGE, Mass. Laboratory Corp. of America Holdings will purchase a clinical testing business from Genzyme, Genzyme said Monday.


The biotech company said LabCorp would buy Genzyme Genetics, its reproductive and cancer testing unit, for $925 million in cash.



“This transaction demonstrates the strategic value of Genzyme Genetics and the strong franchise we’ve built over a 20-year period,” Genzyme chairman and CEO Henri Termeer said. “It also shows how our management team is uniquely positioned to unlock the underappreciated value of Genzyme’s diverse businesses for shareholders.”


Login or Register to post a comment.